356 related articles for article (PubMed ID: 18048502)
1. Derlin-1 and p97/valosin-containing protein mediate the endoplasmic reticulum-associated degradation of human V2 vasopressin receptors.
Schwieger I; Lautz K; Krause E; Rosenthal W; Wiesner B; Hermosilla R
Mol Pharmacol; 2008 Mar; 73(3):697-708. PubMed ID: 18048502
[TBL] [Abstract][Full Text] [Related]
2. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
Robben JH; Knoers NV; Deen PM
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F265-72. PubMed ID: 16006591
[TBL] [Abstract][Full Text] [Related]
3. Disease-causing V(2) vasopressin receptors are retained in different compartments of the early secretory pathway.
Hermosilla R; Oueslati M; Donalies U; Schönenberger E; Krause E; Oksche A; Rosenthal W; Schülein R
Traffic; 2004 Dec; 5(12):993-1005. PubMed ID: 15522100
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
Oksche A; Schülein R; Rutz C; Liebenhoff U; Dickson J; Müller H; Birnbaumer M; Rosenthal W
Mol Pharmacol; 1996 Oct; 50(4):820-8. PubMed ID: 8863826
[TBL] [Abstract][Full Text] [Related]
6. Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane.
Lilley BN; Ploegh HL
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14296-301. PubMed ID: 16186509
[TBL] [Abstract][Full Text] [Related]
7. Polycystin-2 is regulated by endoplasmic reticulum-associated degradation.
Liang G; Li Q; Tang Y; Kokame K; Kikuchi T; Wu G; Chen XZ
Hum Mol Genet; 2008 Apr; 17(8):1109-19. PubMed ID: 18178578
[TBL] [Abstract][Full Text] [Related]
8. Alix (AIP1) is a vasopressin receptor (V2R)-interacting protein that increases lysosomal degradation of the V2R.
Yi X; Bouley R; Lin HY; Bechoua S; Sun TX; Del Re E; Shioda T; Raychowdhury MK; Lu HA; Abou-Samra AB; Brown D; Ausiello DA
Am J Physiol Renal Physiol; 2007 May; 292(5):F1303-13. PubMed ID: 17287200
[TBL] [Abstract][Full Text] [Related]
9. UBXD1 is a VCP-interacting protein that is involved in ER-associated degradation.
Nagahama M; Ohnishi M; Kawate Y; Matsui T; Miyake H; Yuasa K; Tani K; Tagaya M; Tsuji A
Biochem Biophys Res Commun; 2009 May; 382(2):303-8. PubMed ID: 19275885
[TBL] [Abstract][Full Text] [Related]
10. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide.
Schoneberg T; Yun J; Wenkert D; Wess J
EMBO J; 1996 Mar; 15(6):1283-91. PubMed ID: 8635461
[TBL] [Abstract][Full Text] [Related]
11. Yeast Derlin Dfm1 interacts with Cdc48 and functions in ER homeostasis.
Sato BK; Hampton RY
Yeast; 2006; 23(14-15):1053-64. PubMed ID: 17083136
[TBL] [Abstract][Full Text] [Related]
12. Herp enhances ER-associated protein degradation by recruiting ubiquilins.
Kim TY; Kim E; Yoon SK; Yoon JB
Biochem Biophys Res Commun; 2008 May; 369(2):741-6. PubMed ID: 18307982
[TBL] [Abstract][Full Text] [Related]
13. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
Weihl CC; Dalal S; Pestronk A; Hanson PI
Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
[TBL] [Abstract][Full Text] [Related]
14. Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus.
Faerch M; Christensen JH; Rittig S; Johansson JO; Gregersen N; de Zegher F; Corydon TJ
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1518-25. PubMed ID: 19812297
[TBL] [Abstract][Full Text] [Related]
15. Potential of nonpeptide (ant)agonists to rescue vasopressin V2 receptor mutants for the treatment of X-linked nephrogenic diabetes insipidus.
Los EL; Deen PM; Robben JH
J Neuroendocrinol; 2010 May; 22(5):393-9. PubMed ID: 20163515
[TBL] [Abstract][Full Text] [Related]
16. Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.
Robben JH; Sze M; Knoers NV; Deen PM
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F253-60. PubMed ID: 16926443
[TBL] [Abstract][Full Text] [Related]
17. Derlin-dependent accumulation of integral membrane proteins at cell surfaces.
Schaheen B; Dang H; Fares H
J Cell Sci; 2009 Jul; 122(Pt 13):2228-39. PubMed ID: 19509052
[TBL] [Abstract][Full Text] [Related]
18. A fully active nonglycosylated V2 vasopressin receptor.
Innamorati G; Sadeghi H; Birnbaumer M
Mol Pharmacol; 1996 Sep; 50(3):467-73. PubMed ID: 8794883
[TBL] [Abstract][Full Text] [Related]
19. An X-linked NDI mutation reveals a requirement for cell surface V2R expression.
Sadeghi HM; Innamorati G; Birnbaumer M
Mol Endocrinol; 1997 Jun; 11(6):706-13. PubMed ID: 9171234
[TBL] [Abstract][Full Text] [Related]
20. Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation.
Oda Y; Okada T; Yoshida H; Kaufman RJ; Nagata K; Mori K
J Cell Biol; 2006 Jan; 172(3):383-93. PubMed ID: 16449189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
